Literature DB >> 27655616

Occurrence of cardiovascular drugs in the sewage-impacted Vistula River and in tap water in the Warsaw region (Poland).

Joanna Giebułtowicz1, Albert Stankiewicz2, Piotr Wroczyński2, Grzegorz Nałęcz-Jawecki3.   

Abstract

In recent years, cardiovascular diseases were the second most common cause of death worldwide. Therefore, the consumption of drugs used to treat cardiovascular diseases is high. So far, there were no such comprehensive reports regarding the presence of cardiovascular drugs in surface and tap waters, particularly in Central and Eastern Europe. The aim of our study was to determine the presence of 30 pharmaceutically active compounds and some of their metabolites, at specific points of the Vistula River and in tap water samples in the Warsaw region. The analysis was performed using the liquid chromatography-electrospray ionization-tandem mass spectrometry method, coupled to solid-phase extraction. To the best of the authors' knowledge, this is the first time where the presence of ciprofibrate in the environment was investigated. Cardiovascular drugs found at the highest concentrations (reaching 1 μg/L or higher) in surface water were beta-blockers, sartans and diuretics. In tap water samples, trace amounts of pharmaceuticals were detected, for almost all target compounds. This highlights their inadequate elimination by the treatment facility used in the Warsaw region. The presence of cardiovascular compounds in the aquatic environment could have a long-term effect even at a low exposure level, since synergy effects amongst pharmaceuticals may occur.

Entities:  

Keywords:  Cardiovascular; Ecological; Pharmaceuticals; Pollution; Risk; Water

Mesh:

Substances:

Year:  2016        PMID: 27655616     DOI: 10.1007/s11356-016-7668-z

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  27 in total

1.  Removal of pharmaceuticals during drinking water treatment.

Authors:  Thomas A Ternes; Martin Meisenheimer; Derek McDowell; Frank Sacher; Heinz-Jürgen Brauch; Brigitte Haist-Gulde; Gudrun Preuss; Uwe Wilme; Ninette Zulei-Seibert
Journal:  Environ Sci Technol       Date:  2002-09-01       Impact factor: 9.028

2.  Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia.

Authors:  Emma Gracia-Lor; Juan V Sancho; Roque Serrano; Félix Hernández
Journal:  Chemosphere       Date:  2012-01-04       Impact factor: 7.086

3.  Cleanup strategies and advantages in the determination of several therapeutic classes of pharmaceuticals in wastewater samples by SPE-LC-MS/MS.

Authors:  M A Sousa; C Gonçalves; E Cunha; J Hajšlová; M F Alpendurada
Journal:  Anal Bioanal Chem       Date:  2010-10-20       Impact factor: 4.142

4.  Serial mixed-mode cation- and anion-exchange solid-phase extraction for separation of basic, neutral and acidic pharmaceuticals in wastewater and analysis by high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry.

Authors:  Martin Lavén; Tomas Alsberg; Yong Yu; Margaretha Adolfsson-Erici; Hongwen Sun
Journal:  J Chromatogr A       Date:  2008-11-14       Impact factor: 4.759

5.  EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents.

Authors:  Robert Loos; Raquel Carvalho; Diana C António; Sara Comero; Giovanni Locoro; Simona Tavazzi; Bruno Paracchini; Michela Ghiani; Teresa Lettieri; Ludek Blaha; Barbora Jarosova; Stefan Voorspoels; Kelly Servaes; Peter Haglund; Jerker Fick; Richard H Lindberg; David Schwesig; Bernd M Gawlik
Journal:  Water Res       Date:  2013-09-15       Impact factor: 11.236

6.  Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS.

Authors:  Angela L Batt; Mitch S Kostich; James M Lazorchak
Journal:  Anal Chem       Date:  2008-05-23       Impact factor: 6.986

7.  Comparison of different extraction methods for the determination of statin drugs in wastewater and river water by HPLC/Q-TOF-MS.

Authors:  Julia Martín; Wolfgang Buchberger; Esteban Alonso; Markus Himmelsbach; Irene Aparicio
Journal:  Talanta       Date:  2011-04-17       Impact factor: 6.057

8.  Development of a SPE-HPLC-MS/MS method for the determination of most prescribed pharmaceuticals and related metabolites in urban sewage samples.

Authors:  Robert Gurke; Julia Rossmann; Sara Schubert; Tobias Sandmann; Martin Rößler; Reinhard Oertel; Joachim Fauler
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-03-23       Impact factor: 3.205

Review 9.  LC-MS analysis and environmental risk of lipid regulators.

Authors:  M D Hernando; A Agüera; A R Fernández-Alba
Journal:  Anal Bioanal Chem       Date:  2006-09-20       Impact factor: 4.142

10.  Occurrence and fate of the angiotensin II receptor antagonist transformation product valsartan acid in the water cycle--a comparative study with selected β-blockers and the persistent anthropogenic wastewater indicators carbamazepine and acesulfame.

Authors:  Karsten Nödler; Olav Hillebrand; Krzysztof Idzik; Martin Strathmann; Ferry Schiperski; Johannes Zirlewagen; Tobias Licha
Journal:  Water Res       Date:  2013-09-10       Impact factor: 11.236

View more
  2 in total

1.  Determination of Pharmaceuticals, Heavy Metals, and Oxysterols in Fish Muscle.

Authors:  Barbara Bobrowska-Korczak; Agnieszka Stawarska; Arkadiusz Szterk; Karol Ofiara; Małgorzata Czerwonka; Joanna Giebułtowicz
Journal:  Molecules       Date:  2021-02-25       Impact factor: 4.411

2.  Uptake and bio-transformation of telmisartan by cress (Lepidium sativum) from sewage treatment plant effluents using high-performance liquid chromatography/drift-tube ion-mobility quadrupole time-of-flight mass spectrometry.

Authors:  Tamara Lang; Markus Himmelsbach; Franz Mlynek; Wolfgang Buchberger; Christian W Klampfl
Journal:  Environ Sci Pollut Res Int       Date:  2021-05-10       Impact factor: 4.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.